BioSpace News Archive

Strateos, Inc., a pioneer in the development of remote access laboratories and lab control software for life science research, today announced the launch of its SmartLab Software™ which enables research organizations of any size to manage scientific workflows and integrate automation.

CytRx Corporation, a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, announced that it has entered into a securities purchase agreement with a single healthcare-focused institutional investor for aggregate gross proceeds of approximately $10 million.

Artax Biopharma, Inc., a biotechnology company focused on transforming the treatment of T Cell-mediated diseases, today announced that the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted clinical trial authorization to evaluate AX-158 in a Phase 1 clinical trial for the treatment of T Cell-Mediated Diseases.

Food allergy is an increasing problem and one that is not yet fully understood

Guardant Health, Inc., a leading precision oncology company, announced it will report financial results for the second quarter 2021 after market close on Thursday, August 5, 2021.

Adamis Pharmaceuticals Corporation urged its valued stockholders to vote to reelect all five members of the Company’s Board of Directors at the upcoming Annual Meeting of Stockholders on July 16, 2021.

Vyant Bio, Inc. announced today that its wholly-owned subsidiary, StemoniX, Inc. (“StemoniX”), was issued US Patent No. 11054408, titled “ High Throughput Optical Assay of Human Mixed Cell Population Spheroids ” by the United States Patent and Trademark Office (USPTO).

Yield10 Bioscience, Inc., an agricultural bioscience company, announced it has completed planting of its 2021 Field Test and Seed Scale Up program at all contracted sites in the United States, Canada, and Argentina.

Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces an expert analysis titled, “Anemia and Heart Failure: Guidance for Clinicians and Trialists’’ published July 6, 2021 in the American College of Cardiology (ACC) online clinical topics section: https://www.acc.org/latest-in-cardiology/articles/2021/07/06/12/18/anemia-and-heart-failure.

Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2021 financial results on Wednesday, August 4 th , before the market opens. A conference call has been scheduled to discuss this information on Wednesday, August 4 th , at 9:30 a.m. ET.